Re: Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients with Intermediate- or Poor-Risk Germ Cell Tumors Editorial Comment

被引：0
|
作者：
Richie, Jerome P.
机构：
来源：
JOURNAL OF UROLOGY | 2017年 / 198卷 / 02期
关键词：
D O I：
10.1016/j.juro.2017.05.023
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：257 / 257
页数：1
相关论文
共 50 条
  • [41] First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas
    Roberto Castelli
    Luigi Bergamaschini
    Giorgio Lambertenghi Deliliers
    Medical Oncology, 2018, 35
  • [42] Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy
    Beyer, Joerg
    Lorch, Anja
    Beyer, Joerg
    Bascoul-Mollevi, C.
    Kramar, A.
    Einhorn, Lawrence H.
    Necchi, A.
    Massard, C.
    De Giorgi, U.
    Flechon, A.
    Margolin, Kim A.
    Lotz, Jean-Pierre
    Lluch, Jose Ramon Germa
    Powles, Thomas
    Kollmannsberger, Christian K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (33) : 4906 - 4911
  • [43] First-Line Combination Chemotherapy with Cisplatin, Etoposide and Ifosfamide for the Treatment of Disseminated Germ Cell Cancer: Re-Evaluation in the Granulocyte Colony-Stimulating Factor Era
    Tanaka, Hajime
    Yuasa, Takeshi
    Fujii, Yasuhisa
    Sakura, Mizuaki
    Urakami, Shinji
    Yamamoto, Shinya
    Masuda, Hitoshi
    Fukui, Iwao
    Yonese, Junji
    CHEMOTHERAPY, 2013, 59 (06) : 441 - 446
  • [44] First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas
    Castelli, Roberto
    Bergamaschini, Luigi
    Deliliers, Giorgio Lambertenghi
    MEDICAL ONCOLOGY, 2018, 35 (02)
  • [45] The role of paclitaxel in the first-line treatment of patients with 'poor prognosis' germ cell tumor (GCT) undergoing sequential high dose chemotherapy.
    Hartman, JT
    Rick, O
    Thomas, M
    Schleicher, J
    Metzner, B
    Flasshove, M
    Kollmannsberger, C
    Schmoll, HJ
    Kanz, L
    Bokemeyer, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 415S - 415S
  • [46] Re: Conditional Survival of Patients with Metastatic Testicular Germ Cell Tumors Treated with First-Line Curative Therapy
    Richie, Jerome P.
    JOURNAL OF UROLOGY, 2017, 197 (01): : 158 - 158
  • [47] Editorial Comment from Dr Beyer to Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor
    Beyer, Joerg
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (10) : 929 - 930
  • [48] Editorial Comment from Dr Nakamura to Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor
    Nakamura, Terukazu
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (10) : 928 - 928
  • [49] Efficacy of first-line bleomycin, etoposide, and cisplatin chemotherapy for peripheral blood stem cell mobilization in patients with germ cell cancer
    Yamada Y.
    Hara I.
    Gohji K.
    Nakamura I.
    Oka Y.
    Arakawa S.
    Kamidono S.
    International Journal of Clinical Oncology, 1998, 3 (3) : 147 - 151
  • [50] Role of alternative donor allogeneic hematopoietic stem cell transplantation in patients with intermediate- or poor-risk acute myeloid leukemia in first complete remission
    Yano, Shingo
    Yokoyama, Hiroki
    Yanada, Masamitsu
    Mori, Jinichi
    Aoki, Jun
    Ohashi, Kazuteru
    Kanomori, Heiwa
    Ozawa, Yuichiro
    Sawa, Masashi
    Nakamae, Hiroshisa
    Eto, Tetsuya
    Ohta, Shuichi
    Tanaka, Junji
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Takami, Akiyoshi
    BONE MARROW TRANSPLANTATION, 2019, 54 (12) : 2004 - 2012
12345